Representatives from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association and Seoul National University are taking a commemorative photo after signing a business agreement for mutual development. <br>[Photo by Korea Pharmaceutical and Bio-Pharma Manufacturers Association]

Representatives from the Korea Pharmaceutical and Bio-Pharma Manufacturers Association and Seoul National University are taking a commemorative photo after signing a business agreement for mutual development.
[Photo by Korea Pharmaceutical and Bio-Pharma Manufacturers Association]

View original image

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on the 24th that it has signed a Memorandum of Understanding (MOU) with Seoul National University, a national university corporation, to establish pharmaceutical sovereignty, promote industry-academia cooperation, nurture outstanding talent, and activate research for the mutual development of both institutions.


The two institutions held the MOU signing ceremony on the 23rd at the main building of Seoul National University in Gwanak-gu, Seoul, where this was announced. Attending from the Pharmaceutical and Bio-Pharma Manufacturers Association were Chairman Won Hee-mok, Vice Chairman Jang Byung-won, Executive Director Lee Jae-guk, and Heo Kyung-hwa, CEO of the Korea Innovative Medicines Consortium (KIMCo). From Seoul National University, President Yoo Hong-rim, Dean of the College of Pharmacy Lee Sang-guk, Director of Research Kang Byung-chul, and Deputy Director of Research Lee Woo-in were present.


Going forward, the two institutions plan to maximize their strengths and contribute to mutual development through comprehensive partnerships. Specifically, the cooperation will focus on ▲innovation and development of both institutions through joint research and participation in domestic and international projects ▲development and operation of educational programs for talent cultivation and utilization ▲mutual development through cooperation and exchange of technology and talent ▲creation and dissemination of new knowledge and technology.


Chairman Won Hee-mok (Specially Appointed Professor at Seoul National University College of Pharmacy) said, “In open innovation to strengthen the competitiveness of the pharmaceutical and bio industry, academia, which nurtures global talent and produces excellent research outcomes, is the most essential entity, and Seoul National University stands at the forefront. This will be a great opportunity for mutual development in joint research and talent cultivation.”



President Yoo Hong-rim of Seoul National University stated, “I believe that the collaboration between the Pharmaceutical and Bio-Pharma Manufacturers Association and Seoul National University will create a significant synergy effect for the growth of Korea’s pharmaceutical and bio sectors. Through cooperation, the two institutions can establish a new model of industry-academia collaboration and greatly contribute to national economic development and the improvement of public health.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing